
Nabriva Therapeutics plc NBRV
Quartalsbericht 2023-Q1
hinzugefügt 22.05.2023
Nabriva Therapeutics plc ROCE 2011-2026 | NBRV
ROCE Jährlich Nabriva Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1333.89 | -82.86 | -165.68 | -102.6 | -123.5 | -89.41 | -71.15 | -24.65 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -24.65 | -1333.89 | -249.22 |
ROCE Vierteljährlich Nabriva Therapeutics plc
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123.99 | -88.8 | -104.39 | -54.51 | -69.45 | -52.53 | -85.64 | -103.17 | -124.45 | -119.91 | -148.4 | -137.48 | -128.34 | -102.6 | -107.46 | -142.4 | -134.45 | -123.5 | -117.16 | -85.14 | -84.88 | -89.41 | -81.46 | -74.54 | -70.57 | -71.15 | -61.52 | -43.32 | -28.42 | -9.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 123.99 | -148.4 | -84.02 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-299.89 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
64924.32 | - | -10.17 % | $ 12.2 K | ||
|
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
-49.48 | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-368.0 | - | - | $ 269 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.65 | $ 0.83 | -0.96 % | $ 37.9 M | ||
|
Exelixis
EXEL
|
40.35 | $ 46.83 | -3.85 % | $ 12.7 B | ||
|
BioNTech SE
BNTX
|
-4.81 | $ 93.78 | -1.55 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.5 | - | - | $ 231 M | ||
|
Fortress Biotech
FBIO
|
-140.8 | $ 2.48 | -2.94 % | $ 69.2 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
31.5 | $ 22.17 | 3.19 % | $ 3.67 B | ||
|
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
-19.96 | $ 3.14 | -0.32 % | $ 653 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-146.69 | $ 3.66 | 9.25 % | $ 6.03 M | ||
|
Aeterna Zentaris
AEZS
|
-29.95 | - | 5.93 % | $ 314 M | ||
|
Genprex
GNPX
|
-194.87 | $ 0.89 | -0.2 % | $ 830 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-80.33 | - | 1.93 % | $ 17.4 M | ||
|
Genmab A/S
GMAB
|
31.74 | $ 27.74 | -0.54 % | $ 17.1 B | ||
|
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-116.14 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-58.56 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-6.45 | $ 22.41 | -7.3 % | $ 2.85 B | ||
|
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-299.27 | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
394.73 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
123.77 | - | 17.91 % | $ 11.1 M | ||
|
CRISPR Therapeutics AG
CRSP
|
-34.58 | $ 53.95 | -2.05 % | $ 4.85 B | ||
|
Avenue Therapeutics
ATXI
|
-168.29 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-151.88 | $ 1.63 | -4.41 % | $ 434 M | ||
|
AVROBIO
AVRO
|
10.76 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Завод ДИОД
DIOD
|
5.84 | - | - | - | ||
|
Фармсинтез
LIFE
|
-4.03 | - | - | - |